See more : ABM Industries Incorporated (ABM) Income Statement Analysis – Financial Results
Complete financial analysis of Jinhe Biotechnology CO., LTD. (002688.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jinhe Biotechnology CO., LTD., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- UAS Drone Corp. (USDR) Income Statement Analysis – Financial Results
- Business Alignment Public Company Limited (BIZ.BK) Income Statement Analysis – Financial Results
- The Shanghai Commercial & Savings Bank, Ltd. (5876.TW) Income Statement Analysis – Financial Results
- B2Gold Corp. (0QYN.L) Income Statement Analysis – Financial Results
- Ningbo ZhongDa Leader Intelligent Transmission Co., Ltd. (002896.SZ) Income Statement Analysis – Financial Results
Jinhe Biotechnology CO., LTD. (002688.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jinhe.com.cn
About Jinhe Biotechnology CO., LTD.
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. The company was founded in 1990 and is based in Dalian, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.17B | 2.12B | 2.08B | 1.81B | 1.78B | 1.63B | 1.46B | 1.50B | 1.25B | 839.81M | 741.07M | 770.41M | 720.73M | 590.22M | 458.75M | 444.39M |
| Cost of Revenue | 1.57B | 1.51B | 1.43B | 1.18B | 1.13B | 1.01B | 899.32M | 984.47M | 888.77M | 580.17M | 478.69M | 521.78M | 478.77M | 404.62M | 340.26M | 346.49M |
| Gross Profit | 602.51M | 613.79M | 651.07M | 629.95M | 653.13M | 616.33M | 558.50M | 511.22M | 361.70M | 259.64M | 262.38M | 248.62M | 241.96M | 185.60M | 118.49M | 97.89M |
| Gross Profit Ratio | 27.71% | 28.92% | 31.33% | 34.71% | 36.64% | 37.84% | 38.31% | 34.18% | 28.93% | 30.92% | 35.41% | 32.27% | 33.57% | 31.45% | 25.83% | 22.03% |
| Research & Development | 96.64M | 82.28M | 72.25M | 66.36M | 60.70M | 40.51M | 33.53M | 11.31M | 5.68M | 4.20M | 3.39M | 1.90M | 931.43K | 1.01M | 706.46K | 0.00 |
| General & Administrative | 85.05M | 57.76M | 57.31M | 59.27M | 52.53M | 58.21M | 50.64M | 45.14M | 35.98M | 23.65M | 19.30M | 26.36M | 21.56M | 22.52M | 13.40M | 36.97M |
| Selling & Marketing | 143.08M | 130.72M | 122.51M | 113.21M | 129.56M | 131.79M | 113.49M | 96.88M | 68.98M | 54.78M | 57.87M | 46.87M | 40.94M | 35.92M | 28.28M | 19.72M |
| SG&A | 227.42M | 188.48M | 179.81M | 172.48M | 182.09M | 190.00M | 164.13M | 142.02M | 104.96M | 78.43M | 77.17M | 73.23M | 62.50M | 58.44M | 41.68M | 56.69M |
| Other Expenses | 173.71M | 171.00M | 168.07M | 159.81M | 153.25M | 135.60M | 127.98M | 9.41M | 7.61M | 11.06M | 2.53M | 9.12M | 4.28M | 2.65M | 419.82K | -381.50K |
| Operating Expenses | 497.78M | 441.76M | 420.13M | 398.65M | 396.04M | 366.11M | 325.63M | 291.56M | 220.03M | 172.23M | 149.21M | 134.63M | 128.01M | 102.80M | 73.39M | 59.01M |
| Cost & Expenses | 2.07B | 1.95B | 1.85B | 1.58B | 1.53B | 1.38B | 1.22B | 1.28B | 1.11B | 752.40M | 627.90M | 656.42M | 606.78M | 507.41M | 413.65M | 405.50M |
| Interest Income | 8.52M | 1.90M | 1.72M | 9.48M | 3.42M | 831.64K | 1.38M | 1.20M | 1.95M | 2.05M | 5.50M | 3.83M | 203.78K | 171.53K | 71.39K | -0.54 |
| Interest Expense | 60.17M | 46.56M | 56.27M | 60.35M | 61.32M | 50.06M | 38.53M | 26.46M | 27.68M | 3.01M | 2.96M | 14.27M | 15.89M | 15.57M | 14.21M | 19.67M |
| Depreciation & Amortization | 180.93M | 158.03M | 134.09M | 123.16M | 101.00M | 87.65M | 73.50M | 55.81M | 54.10M | 41.93M | 37.10M | 38.55M | 38.41M | 34.43M | 31.82M | 21.11M |
| EBITDA | 271.71M | 284.61M | 357.59M | 326.90M | 380.97M | 330.91M | 258.32M | 297.87M | 210.37M | 142.66M | 148.23M | 160.77M | 145.74M | 114.19M | 77.19M | 38.88M |
| EBITDA Ratio | 12.50% | 17.00% | 17.21% | 18.63% | 23.47% | 21.99% | 18.99% | 20.76% | 17.10% | 17.08% | 20.64% | 21.29% | 21.29% | 19.93% | 16.83% | 8.91% |
| Operating Income | 104.73M | 205.02M | 225.51M | 218.19M | 318.86M | 271.85M | 204.36M | 209.21M | 120.92M | 83.41M | 106.78M | 99.08M | 87.33M | 61.54M | 31.74M | 18.49M |
| Operating Income Ratio | 4.82% | 9.66% | 10.85% | 12.02% | 17.89% | 16.69% | 14.02% | 13.99% | 9.67% | 9.93% | 14.41% | 12.86% | 12.12% | 10.43% | 6.92% | 4.16% |
| Total Other Income/Expenses | -3.24M | -2.40M | 3.20M | -77.28M | -98.66M | -77.33M | -56.99M | 6.11M | 7.63M | 10.80M | 1.39M | 8.80M | -14.83M | -14.89M | -13.71M | -381.51K |
| Income Before Tax | 101.50M | 118.84M | 142.91M | 140.91M | 220.20M | 194.52M | 147.37M | 215.32M | 128.54M | 94.22M | 108.16M | 107.88M | 91.44M | 64.19M | 32.16M | 18.11M |
| Income Before Tax Ratio | 4.67% | 5.60% | 6.88% | 7.76% | 12.35% | 11.94% | 10.11% | 14.40% | 10.28% | 11.22% | 14.60% | 14.00% | 12.69% | 10.88% | 7.01% | 4.08% |
| Income Tax Expense | 7.06M | 804.28K | 20.82M | 1.71M | 29.87M | 30.11M | 37.32M | 41.09M | 12.79M | 14.14M | 17.53M | 18.32M | 14.51M | 10.97M | 6.12M | 3.33M |
| Net Income | 86.46M | 118.04M | 93.99M | 117.32M | 184.94M | 163.63M | 108.42M | 164.13M | 104.65M | 77.21M | 90.43M | 89.58M | 77.40M | 52.75M | 27.03M | 15.87M |
| Net Income Ratio | 3.98% | 5.56% | 4.52% | 6.47% | 10.38% | 10.05% | 7.44% | 10.97% | 8.37% | 9.19% | 12.20% | 11.63% | 10.74% | 8.94% | 5.89% | 3.57% |
| EPS | 0.11 | 0.15 | 0.14 | 0.18 | 0.29 | 0.26 | 0.17 | 0.26 | 0.19 | 0.14 | 0.17 | 0.19 | 0.19 | 0.13 | 0.07 | 0.04 |
| EPS Diluted | 0.11 | 0.15 | 0.14 | 0.18 | 0.29 | 0.26 | 0.17 | 0.26 | 0.19 | 0.14 | 0.17 | 0.19 | 0.19 | 0.13 | 0.07 | 0.04 |
| Weighted Avg Shares Out | 780.30M | 780.41M | 671.37M | 635.29M | 635.29M | 629.34M | 635.29M | 631.27M | 544.60M | 551.50M | 538.29M | 465.18M | 407.39M | 408.44M | 408.40M | 408.38M |
| Weighted Avg Shares Out (Dil) | 780.30M | 780.41M | 671.37M | 635.29M | 635.29M | 629.34M | 637.79M | 631.27M | 550.80M | 551.50M | 538.29M | 466.55M | 407.39M | 408.44M | 408.40M | 408.38M |
Source: https://incomestatements.info
Category: Stock Reports